Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Werdelin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|July 3, 1995
[Use of molecular biology in neurology]L M Werdelin
Nordisk Medicin|January 1, 1994
[Treatment of dyskinetic syndromes]L M Werdelin, H Pakkenberg
Ugeskrift for Laeger|August 22, 1994
[Treatment of dyskinetic syndromes]L M Werdelin, H Pakkenberg
Ugeskrift for Laeger|February 18, 1991
[Amyotrophic lateral sclerosis: an autoimmune disease?]P R Hansen, L M Werdelin
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2002
Constipation in neurological diseasesK Winge, D Rasmussen, L M Werdelin
Ugeskrift for Laeger|October 2, 2001
[Neurogenic bladder disturbances]K Winge, L M Werdelin, R Iversen-Hansen
Ugeskrift for Laeger|October 3, 2000
[Hereditary dystonias]L E Hjermind, S A Sørensen, L M Werdelin
Ugeskrift for Laeger|November 9, 2000
[Neurosurgical treatment of Parkinson disease]J Brennum, F F Madsen, L Regeur, et al.
Ugeskrift for Laeger|February 24, 2001
[Botulinum toxin treatment of patients with oromandibular dystonia]J Erdal, L M Werdelin, S Prytz, et al.
European Journal of Neurology|December 3, 2003
Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxinM Bakke, L M Werdelin, T Dalager, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|July 3, 1995
[Use of molecular biology in neurology]L M Werdelin
Nordisk Medicin|January 1, 1994
[Treatment of dyskinetic syndromes]L M Werdelin, H Pakkenberg
Ugeskrift for Laeger|August 22, 1994
[Treatment of dyskinetic syndromes]L M Werdelin, H Pakkenberg
Ugeskrift for Laeger|February 18, 1991
[Amyotrophic lateral sclerosis: an autoimmune disease?]P R Hansen, L M Werdelin
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2002
Constipation in neurological diseasesK Winge, D Rasmussen, L M Werdelin
Ugeskrift for Laeger|October 2, 2001
[Neurogenic bladder disturbances]K Winge, L M Werdelin, R Iversen-Hansen
Ugeskrift for Laeger|October 3, 2000
[Hereditary dystonias]L E Hjermind, S A Sørensen, L M Werdelin
Ugeskrift for Laeger|November 9, 2000
[Neurosurgical treatment of Parkinson disease]J Brennum, F F Madsen, L Regeur, et al.
Ugeskrift for Laeger|February 24, 2001
[Botulinum toxin treatment of patients with oromandibular dystonia]J Erdal, L M Werdelin, S Prytz, et al.
European Journal of Neurology|December 3, 2003
Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxinM Bakke, L M Werdelin, T Dalager, et al.
Pageof 2